IDEOLOGÍA Y DESEO. PARA UN DIÁLOGO ENTRE ALTHUSSER Y DELEUZE/GUATTARI
Agora. Papeles de Filosofía · 10.11.2025 · 44 (2)
DOI: 10.15304/ag.44.2.10316 ↗Kurz gefasst
Fachartikel in der Zeitschrift Agora. Papeles de Filosofía, online erschienen am 10.11.2025. Verfasst von Santiago Lo Vuolo. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
This paper analyzes the controversy between desire and ideology in Althusser and Deleuze/Guattari, arguing that their approaches–despite irreducible differences–function as complementary lenses to diagnose subjection in late capitalism. First, we examine the materialist theory of desire in Anti-Oedipus, where phenomena like fascism stem from infrastructural libidinal economies, not ideological illusions. Second, we review Althusser’s reconceptualization of ideology as a material practice that interpellates subjects, abandoning appearance/essence metaphysics. Third, we establish their common goal: deconstructing the sovereign subject. Finally, we contend that their radical divergence (subjectivation as an effect of capital itself, not superstructural apparatuses) enables critical articulation: ideology captures desiring-flows, but these flows exceed capture, generating lines of flight. This tension enriches tools to confront desire-monetizing capitalism, combining the critique of alienating interpellations (Althusser) with the micropolitics of collective assemblages (Deleuze/Guattari).
Zitieren
APA
Vuolo, S. L. (2025). IDEOLOGÍA Y DESEO. PARA UN DIÁLOGO ENTRE ALTHUSSER Y DELEUZE/GUATTARI. Agora. Papeles de Filosofía, 44(2). https://doi.org/10.15304/ag.44.2.10316
Vancouver
Vuolo SL. IDEOLOGÍA Y DESEO. PARA UN DIÁLOGO ENTRE ALTHUSSER Y DELEUZE/GUATTARI. Agora. Papeles de Filosofía. 2025;44(2). doi:10.15304/ag.44.2.10316
BibTeX
@article{Vuolo2025,
author = {Vuolo, Santiago Lo},
title = {IDEOLOGÍA Y DESEO. PARA UN DIÁLOGO ENTRE ALTHUSSER Y DELEUZE/GUATTARI},
journal = {Agora. Papeles de Filosofía},
year = {2025},
volume = {44},
number = {2},
doi = {10.15304/ag.44.2.10316}
}
EUVIMED